Aspire Pharma Limited
06828501
Healthy
- Going concern doubt noted in accounts (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 15/06/2020
DIRECTOR
BRITISH · ENGLAND · Age 40
Also on 13 other boards
director · Since 15/06/2020
DIRECTOR
BRITISH · ENGLAND · Age 56
Also on 12 other boards
director · Since 28/04/2023
DIRECTOR
BRITISH · ENGLAND · Age 49
Also on 10 other boards
Persons with Significant Control
Aphl 2 Limited
102, High Street, Godalming, GU7 1DS
Reg: 11534571 · Companies House · Limited Company
Notified 19/09/2019
Former PSCs
Aspire Pharma Holdings Limited
Ceased 04/09/2019
Aphl 1 Limited
Ceased 19/09/2019
Charges1 outstanding
ARES MANAGEMENT LIMITED (AS SECURITY TRUSTEE FOR THE SECURED PARTIES (AS DEFINED WITHIN THE INS
BARRY SONENFELD · ANDREE LISA SONENFELD · JOE KERRIDGE
BARCLAYS BANK PLC
LLOYDS BANK PLC
CompanyRankvs 170+ SIC 46460 peers70
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to
Key FinancialsYear ending 31/12/2024
Net Worth
£65.8M
Balance sheet strength
Cash
£8.5M
Cash in the bank
Profit Before Tax
£24.9M
Bottom line earnings
Net Current Assets
£42.6M
Working capital
Current Assets
£72.0M
Current Liabilities
£29.5M
Fixed Assets
£24.3M
Debtors
£32.7M
Cost of Sales
£70.4M
Admin Expenses
£20.2M
Profit After Tax
£23.1M
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 2.45 | +£17.3M |
| 2023 | 21079904.67 | +£291k |
| 2022 | 3.12 | +£2.0M |
| 2021 | 3.34 | +£7.5M |
| 2020 | 3.47 | +£9.7M |
| 2019 | 2.02 | — |
Derived from filed accounts. Not audited figures.